Ignite Creation Date:
2024-05-05 @ 11:29 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00050986
Status:
COMPLETED
Last Update Posted:
2020-09-22
First Post:
2002-12-31
Brief Title:
Phase III Evaluation of Temozolomide and ZARNESTRA R115777 for Recurrent and Progressive Glioblastoma Multiforme
Sponsor:
MD Anderson Cancer Center
Organization:
MD Anderson Cancer Center
Key Dates - Follows AllAPIJSON File Order
Start Date:
2002-12
Start Date Type:
None
Primary Completion Date:
2008-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-10
Completion Date Type:
ACTUAL
First Submit Date:
2002-12-31
First Submit QC Date:
January 2 2003
Study First Post Date:
2003-01-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2010-09-16
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-09-01
Last Update Post Date:
2020-09-22
Last Update Post Date Type:
ACTUAL